Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer Progression
Although treatment options in breast cancer have been improved significantly, predictive biomarkers for disease progression and metastasis are still lacking. Recent studies indicate that several TNF Receptor Superfamily members are involved in breast cancer cell proliferation and survival. Interesti...
Main Authors: | Clemens Hinterleitner, Yanjun Zhou, Claudia Tandler, Jonas S. Heitmann, Korbinian N. Kropp, Martina Hinterleitner, André Koch, Andreas D. Hartkopf, Lars Zender, Helmut R. Salih, Stefanie Maurer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.642170/full |
Similar Items
-
Regulation of Platelet-Derived ADAM17: A Biomarker Approach for Breast Cancer?
by: Yanjun Zhou, et al.
Published: (2021-06-01) -
The TNFSF Members APRIL and BAFF and Their Receptors TACI, BCMA, and BAFFR in Oncology, With a Special Focus in Breast Cancer
by: Marilena Kampa, et al.
Published: (2020-06-01) -
Long‐term remission of small cell lung cancer after reactivation of tuberculosis following immune‐checkpoint blockade: A case report
by: Mattia Sirgiovanni, et al.
Published: (2021-03-01) -
Inhibition of NK Reactivity Against Solid Tumors by Platelet-Derived RANKL
by: Kim L. Clar, et al.
Published: (2019-02-01) -
Association of Common Variants of <i>TNFSF13</i> and <i>TNFRSF13B </i>Genes with CLL Risk and Clinical Picture, as Well as Expression of Their Products—APRIL and TACI Molecules
by: Monika Jasek, et al.
Published: (2020-10-01)